MCM
RMD icon

Montibus Capital Management’s ResMed RMD Stock Holding History

Montibus Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$331K Sell
6,268
-166
-3% -$8.05K 0.04% 100
2013
Q2 		$290K Buy
+6,434
New +$305K 0.04% 100

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
LCG
Luxor Capital Group New York $1.43B AUM 30.88% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Montibus Capital Management's RMD Position: Q3 2013 in Review

Montibus Capital Management reduced its ResMed (RMD) stake by 2.6% in Q3 2013, selling an estimated $8.05K and leaving 6,268 shares worth $331K. The position accounts for 0.04% of the portfolio, ranked #100.

Montibus Capital Management first reported a position in RMD in Q2 2013 and has held it in 2 quarters since. 322 funds tracked by Wall St. Rank hold RMD as of Q3 2013.

  • Montibus Capital Management held 6,268 shares of ResMed worth $331K as of Q3 2013.
  • Montibus Capital Management sold 166 ResMed shares in Q3 2013, an estimated $8.05K.
  • ResMed made up 0.04% of Montibus Capital Management's portfolio in Q3 2013, its #100 holding.
  • Montibus Capital Management first reported a position in ResMed in Q2 2013 and has held it in 2 quarters since.
  • 322 funds tracked by Wall St. Rank held ResMed as of Q3 2013.

Based on Montibus Capital Management's 13F filing for Q3 2013, filed 13 Nov 2013.